doi: 10.3389/fendo.2022.882998 Received 24 February 2022 Accepted 21 September 2022 Published 10 October 2022 Volume 13 - 2022 Edited by ke Sjholm, Gvle Hospital, Sweden Reviewed by Zhanna Belaya, Endocrinology Research Center, Russia
While results are promising, more research is needed to determine the long-term safety and effectiveness of this medication
The authors claim that it is the most comprehensive collection of evidence on post-GLP-1RA weight outcomes to date. Weight regain after GLP-1 discontinuation The study searched multiple databases for randomized controlled trials (RCTs), non-randomized interventional studies, and observational studies examining weight trajectories after discontinuing GLP-1RAs
In vitro, measurements revealed that the increase in cortical BMC was due to an increased cross-sectional bone area, whereas the cortical volumetric BMD was unchanged
[DOI] [PMC free article] [PubMed] [Google Scholar] 75.Yarema M.C., Johnson D.W., Berlin R.J., Sivilotti M.L., Nettel-Aguirre A., Brant R.F., Spyker D.A., Bailey B., Chalut D., Lee J.S., Plint A.C., Purssell R.A., Rutledge T., Seviour C.A., Stiell I.G., Thompson M., Tyberg J., Dart R.C., Rumack B.H
